| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.29 | 5e-08 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-05 |